356 related articles for article (PubMed ID: 27390541)
1. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.
Bae YJ; Yoon YI; Yoon TJ; Lee HJ
Korean J Radiol; 2016; 17(4):497-508. PubMed ID: 27390541
[TBL] [Abstract][Full Text] [Related]
2. Survivin small interfering RNA transfected with a microbubble and ultrasound exposure inducing apoptosis in ovarian carcinoma cells.
Wang Jj; Zheng Y; Yang F; Zhao P; Li Hf
Int J Gynecol Cancer; 2010 May; 20(4):500-6. PubMed ID: 20442583
[TBL] [Abstract][Full Text] [Related]
3. Targeted Microbubbles for Ultrasound Mediated Short Hairpin RNA Plasmid Transfection to Inhibit Survivin Gene Expression and Induce Apoptosis of Ovarian Cancer A2780/DDP Cells.
Zhang Y; Chang S; Sun J; Zhu S; Pu C; Li Y; Zhu Y; Wang Z; Xu RX
Mol Pharm; 2015 Sep; 12(9):3137-45. PubMed ID: 26212628
[TBL] [Abstract][Full Text] [Related]
4. Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.
Cui M; Au JL; Wientjes MG; O'Donnell MA; Loughlin KR; Lu Z
J Urol; 2015 Jul; 194(1):230-7. PubMed ID: 25681288
[TBL] [Abstract][Full Text] [Related]
5. Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis.
Chen ZY; Liang K; Qiu RX
J Exp Clin Cancer Res; 2010 Nov; 29(1):152. PubMed ID: 21092274
[TBL] [Abstract][Full Text] [Related]
6. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
7. Novel ultrasound-targeted microbubble destruction mediated short hairpin RNA plasmid transfection targeting survivin inhibits gene expression and induces apoptosis of HeLa cells.
Chen Z; Liang K; Xie M; Wang X; Lü Q; Zhang J
Mol Biol Rep; 2009 Nov; 36(8):2059-67. PubMed ID: 18991017
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-targeted microbubble destruction combined with dual targeting of HSP72 and HSC70 inhibits HSP90 function and induces extensive tumor-specific apoptosis.
Wang H; Song Y; Hao D; Bai M; Jin L; Gu J; Su Y; Liu L; Jia C; Du L
Int J Oncol; 2014 Jul; 45(1):157-64. PubMed ID: 24736948
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity.
Shen J; Liu J; Long Y; Miao Y; Su M; Zhang Q; Han H; Hao X
Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):223-30. PubMed ID: 19280061
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment.
Luo W; Wen G; Yang L; Tang J; Wang J; Wang J; Zhang S; Zhang L; Ma F; Xiao L; Wang Y; Li Y
Theranostics; 2017; 7(2):452-465. PubMed ID: 28255342
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin liposome-loaded microbubbles for contrast imaging and ultrasound-triggered drug delivery.
Escoffre JM; Mannaris C; Geers B; Novell A; Lentacker I; Averkiou M; Bouakaz A
IEEE Trans Ultrason Ferroelectr Freq Control; 2013 Jan; 60(1):78-87. PubMed ID: 23287915
[TBL] [Abstract][Full Text] [Related]
13. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
Li Z; Zhang L; Tang C; Yin C
Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.
Xiao Y; Jaskula-Sztul R; Javadi A; Xu W; Eide J; Dammalapati A; Kunnimalaiyaan M; Chen H; Gong S
Nanoscale; 2012 Nov; 4(22):7185-93. PubMed ID: 23070403
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved.
Lentacker I; Geers B; Demeester J; De Smedt SC; Sanders NN
Mol Ther; 2010 Jan; 18(1):101-8. PubMed ID: 19623162
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
[TBL] [Abstract][Full Text] [Related]
19. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth.
Su Y; Yu L; Liu N; Guo Z; Wang G; Zheng J; Wei M; Wang H; Yang AG; Qin W; Wen W
Cancer Lett; 2013 Sep; 338(2):282-91. PubMed ID: 23752065
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]